Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY: XLV )

143.83 -0.77 (-0.53%)
Official Closing Price Updated: 8:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Leading And Lagging Sectors For January 31, 2025
Via Benzinga
How We Can Trade On GDP
What we got today, of course, was advance GPD, which is the earliest measure and also the most likely to provoke a reaction in stocks. 
Via Talk Markets
Topics Commodities Futures Stocks / Equities
Leading And Lagging Sectors For January 30, 2025
Via Benzinga
Leading And Lagging Sectors For January 29, 2025
Via Benzinga
Does China AI Threaten US Tech Dominance?
Anxiety about the competitive threat from Chinese artificial intelligence lab DeepSeek triggered a sharp selloff in US equities on Monday, with the worst of the decline centered in tech. 
Via Talk Markets
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
Leading And Lagging Sectors For January 28, 2025
Via Benzinga
Biotech And Healthcare Stocks Poised For Gains Ahead
The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech. 
Via Talk Markets
Topics ETFs Stocks / Equities
Leading And Lagging Sectors For January 27, 2025
Via Benzinga
Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High
The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats. 
Via Stocktwits
Exposures COVID-19
Leading And Lagging Sectors For January 24, 2025
Via Benzinga
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
The firm’s medical-loss ratio (MLR) rose to 92.4% due to Medicaid-related costs but was better than expected. 
Via Stocktwits
Leading And Lagging Sectors For January 23, 2025
Via Benzinga
J&J Stock Dips As 2025 Sales Guidance Misses Estimate, But Retail Mood Resilient
During the earnings call, J&J highlighted several growth drivers, including its positioning for 5%-7% annual growth through 2030 and plans to increase its dividend annually. 
Via Stocktwits
Topics Earnings
Exposures Financial
Leading And Lagging Sectors For January 22, 2025
Via Benzinga
Small Caps Soar, Apple Slips, Treasury Yields Fall On Trump Day 2: What's Driving Markets Tuesday?
Wall Street saw a strong preference for small and mid-cap equities, with the Russell 2000 index leading the market as investors bet on more domestic-friendly policies following Donald Trump's... 
Via Benzinga
Topics Government
Exposures Political
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump
In 2023, Moderna initiated a Phase 1/2 study to assess the safety and immunogenicity of its investigational bird flu vaccine, mRNA-1018, in healthy adults aged 18 and older. 
Via Stocktwits
Leading And Lagging Sectors For January 21, 2025
Via Benzinga
Leading And Lagging Sectors For January 20, 2025
Via Benzinga
ETFs In Focus Post UnitedHealth's Mixed Q4 Results
UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the... 
Via Talk Markets
Topics ETFs Stocks / Equities
Wall Street Roars Ahead Of Trump's Inauguration, Intel Rallies, Bitcoin Tops $105,000: What's Driving Markets Friday?
Risk appetite surged on Wall Street at the end of the week, with investors ramping up stock purchases ahead of Monday's market closure for Martin Luther King Day, which is also when Donald Trump will... 
Via Benzinga
Topics Government
Exposures Political
Stocks Pause, Chipmakers Rise, Gold Hits 2-Month Highs: What's Driving Markets Thursday?
Wall Street paused for a breather on Thursday, following Wednesday's big rally sparked by a softer-than-predicted December inflation report that fueled speculation on the Federal Reserve delivering... 
Via Benzinga
Topics Economy
Exposures Interest Rates
UnitedHealth's Q4 Revenue Miss Depresses Stock Price And Retail Sentiment Alike
The company's full-year medical loss ratio, a key metric tracking the percentage of premiums paid out for medical expenses, rose to 85.5% from 83.2% in 2023. 
Via Stocktwits
Leading And Lagging Sectors For January 16, 2025
Via Benzinga
Intuitive Surgical Stock Hits All-Time High After Prelim Q4 Results Outpace Expectations: Retail Goes All In
Intuitive said worldwide da Vinci procedure volumes grew 18% in Q4 and 17% in 2024, driven by U.S. general surgery and international cancer procedures. 
Via Stocktwits
Wall Street Rallies As Treasury Yields Fall, Banks Smash Q4 Earnings, Oil Hits $80: What's Driving Markets Wednesday?
Wall Street staged a strong rebound on Wednesday, as mixed inflation data bolstered investor confidence in the Federal Reserve's continuation of easing cycle in 2025, easing recent market anxieties. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Eli Lilly Gets Wall Street Backing After Tuesday’s Turmoil, Stock Rises Premarket As Retail Stays Bullish
JPMorgan's Chris Schott reportedly called the stock dip following the Q4 sales miss a buying opportunity. 
Via Stocktwits
Topics Earnings
Exposures Financial
Leading And Lagging Sectors For January 15, 2025
Via Benzinga
Stocks Fail To Rise Despite Benign Producer Inflation, 30-Year Treasury Yields Hit 5%, Ely Lilly Tumbles: What's Driving Markets Tuesday?
A cooler-than-expected December producer inflation report failed to ignite lasting gains on Wall Street Tuesday, reflecting lingering concerns about persistently high inflation among investors. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight-Loss Drug Sales Miss, But Retail Bullish On 2025 Projections
The pharma giant expects continued growth for Mounjaro and Zepbound this year, supported by expanded manufacturing capacity and new market launches. 
Via Stocktwits
Topics Earnings
Exposures Financial
We’re In A Bullish Correction
Over the past month, we’ve seen two downtrodden sectors - energy and healthcare - emerge as leaders. But in the grand scheme of things, not much has changed when it comes to the bull market. 
Via Talk Markets
Topics Stocks / Equities
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.